EBV-microRNAs as Potential Biomarkers in EBV-related Fever: A Narrative Review

Curr Mol Med. 2024;24(1):2-13. doi: 10.2174/1566524023666221118122005.

Abstract

At present, timely and accurate diagnosis and effective treatment of Epstein- Barr Virus (EBV) infection-associated fever remain a difficult challenge. EBV encodes 44 mature microRNAs (miRNAs) that inhibit viral lysis, adjust inflammatory response, regulate cellular apoptosis, promote tumor genesis and metastasis, and regulate tumor cell metabolism. Herein, we have collected the specific expression data of EBV-miRNAs in EBV-related fevers, including infectious mononucleosis (IM), EBVassociated hemophagocytic lymphohistiocytosis (EBV-HLH), chronic active EBV infection (CAEBV), and EBV-related tumors, and proposed the potential value of EBVmiRNAs as biomarkers to assist in the identification, diagnosis, and prognosis of EBVrelated fever, as well as therapeutic targets for drug development.

Keywords: EBV-related fevers; Epstein-Barr; biomarker.; microRNAs; therapeutic targets; virus.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Epstein-Barr Virus Infections* / complications
  • Epstein-Barr Virus Infections* / diagnosis
  • Epstein-Barr Virus Infections* / genetics
  • Herpesvirus 4, Human / genetics
  • Humans
  • Infectious Mononucleosis*
  • MicroRNAs* / genetics

Substances

  • MicroRNAs
  • Biomarkers